Filter Articles
Research in CIDP: Are we making progress?
By Jeffrey A. Allen, MDMember, GBS|CIDP Foundation Global Medical Advisory Board CIDP as a namedβ¦
A 30th Celebration to Remember
Cheers to 30 Years!Β It was the best of all worlds this past November atβ¦
Subcutaneous Immunoglobulin: A Newly Approved Treatment Option for CIDP
David Saperstein, MDCo-Director GBS/CIDP Center of ExcellencePhoenix Neurological AssociatesPhoenix, AZ Intravenous immunoglobulin (IVIg) is oneβ¦
Vaccines and Guillain Barre Syndrome 2018
Infections and vaccines have been hypothesized to play a role in triggering the development ofβ¦
2018 Research Grant Finalists Announced
Research is critical to serving the cause and the community. The GBS-CIDP Foundation International believesβ¦
Founder Estelle Benson Named 2018 NORD Honoree for Abbey S. Meyers Leadership Award
March 21, 2018 β The National Organization for Rare Disorders (NORD) today announced the people,β¦
FDA approves CSL Behring treatment for CIDP
The Food and Drug Administration granted marketing clearanceΒ FridayΒ for Hizentra, a treatment for chronic inflammatory demyelinatingβ¦
2017 GBS|CIDP Foundation Grant Awardees
(#1)Β Title of the project:Β Enhance Peripheral Nerve Repair by Modulating Macrophage Subsets Investigator: Gang Zhang, M.D;β¦
Research Published on Quality of Life in Inflammatory Neuropathies: the IN-Qol
In 2008 the GBS|CIDP Foundation awarded a $60,000 to Ingemar S. J. Merkies, MD, PHDβ¦
Hansa Medical receives FDA Orphan Drug Designation for IdeS and the treatment of Guillain-BarrΓ© syndrome
February 16, 2018 Hansa Medical today announced that the U.S. Food and Drug Administration (FDA)β¦
Interlaken Leadership Awards
The Interlaken Leadership Awards support original research in the field of neuroimmunology. Investigators whose proposalsβ¦
Towards an affordable treatment of GBS for patients from low-income countries
Guillain-BarrΓ© syndrome (GBS) takes its toll on the resource poor developing countries where the incidenceβ¦
A dose-response trial of IV immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)/DRIP study
K. Kuitwaard1,2, E Brusse1, A.F.J.E. Vrancken4, F. Eftimov5, N.C. Notermans4, A.J. van der Kooi5, I.S.J.β¦
Charity Navigator Names GBS|CIDP Foundation as ‘Charity Worth Watching’
10 Charities Worth Watching Many of America's most effective charities are also household names. Butβ¦
Announcing the 2017 GBS|CIDP Foundation Grant Awardees
2017 GBS|CIDP Foundation Grant Awardees (#1)Β Title of the project:Β Enhance Peripheral Nerve Repair by Modulating Macrophageβ¦